Nov 6, 2026, 14:57
Rahul Thakur: Pretransplant Biomarkers Linked to Post Transplant GVHD and Survival at ASH 2026
Rahul Thakur, Oncology Fellow at Roswell Park Comprehensive Cancer Center, shared a post on LinkedIn:
“Pleased to share that our research has been selected for an oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting and recognized with a 2026 ASH Abstract Achievement Award.
Abstract 572: Pretransplant amphiregulin and CXCL9 are associated with graft versus host disease and survival following allogeneic hematopoietic cell transplantation
- Sunday, December 13, 2026
- 9:45–10:00 AM
- MCCNO, Rooms 353–355 | New Orleans
Special thanks to Shernan Holtan, MD, Megan M. Herr for her mentorship and guidance, and to the faculty at Roswell Park Comprehensive Cancer Center for their support.
Looking forward to presenting our work at ASH 26!”
Stay updated with Hemostasis Today.
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights